Compounds > rc 3095
Page last updated: 2024-09-03

rc 3095 and Carcinoma, Anaplastic

rc 3095 has been researched along with Carcinoma, Anaplastic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halmos, G; Pinski, J; Schally, AV; Szepeshazi, K1
Groot, K; Halmos, G; Schally, AV; Szepeshazi, K1
Arencibia, JM; Cai, RZ; Groot, K; Halmos, G; Kahán, Z; Schally, AV; Sun, B1

Other Studies

3 other study(ies) available for rc 3095 and Carcinoma, Anaplastic

ArticleYear
Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice.
    International journal of cancer, 1993, Dec-02, Volume: 55, Issue:6

    Topics: Animals; Antineoplastic Agents; Bombesin; Carcinoma; Cell Division; ErbB Receptors; Male; Mice; Mice, Nude; Neoplasm Transplantation; Organ Size; Peptide Fragments; Prostatic Neoplasms; Receptors, Bombesin; Receptors, Somatostatin; Somatostatin; Transplantation, Heterologous; Tumor Cells, Cultured

1993
Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters.
    International journal of cancer, 1993, May-08, Volume: 54, Issue:2

    Topics: Animals; Body Weight; Bombesin; Carcinoma; Cricetinae; Dose-Response Relationship, Drug; Down-Regulation; Epidermal Growth Factor; ErbB Receptors; Female; Gastrin-Releasing Peptide; Gastrins; Growth Hormone; Insulin-Like Growth Factor I; Mesocricetus; Nitrosamines; Pancreatic Neoplasms; Peptide Fragments; Peptides; Receptors, Bombesin; Receptors, Neurotransmitter

1993
Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
    Cancer, 2000, Mar-15, Volume: 88, Issue:6

    Topics: Animals; Antineoplastic Agents; Bombesin; Breast Neoplasms; Carcinoma; Dose-Response Relationship, Drug; ErbB Receptors; Female; Gastrin-Releasing Peptide; Gene Expression Regulation, Neoplastic; Humans; Injections, Subcutaneous; Mice; Mice, Nude; Neoplasm Transplantation; Neurokinin B; Peptide Fragments; Polymerase Chain Reaction; Receptors, Bombesin; Remission Induction; RNA, Messenger; Transplantation, Heterologous; Tumor Cells, Cultured

2000